Kimura et al. noted that the emergence of chronic lung disease in sJIA coincided with the introduction of IL-1 and IL-6 blockade and decreasing use of glucocorticoids, suggesting the potential contribution of drug exposure (43). The gene discussed is IL1B; the disease is chronic lung disease.